Register entry

KBI Biopharma, Inc.

Data as of · How to read this entry

Registered sites
4
Active NDC listings
0
Live patents
0
Countries
2
Base
United States
Authorisation

Registered operations

Analytical testing4Active ingredient (API) manufacture3Finished drug manufacture3
Sites

Registered establishments

4
EstablishmentAddressRegistered forFEI / DUNS
KBI Biopharma SARegistrant: KBI Biopharma, Inc.Route de la Galaise 36, Plan-les-Ouates, Ginevra 1228, Switzerland (CHE)Analytical testing3022997121480487319
KBI Biopharma, Inc.2500 Central Ave., Boulder, Colorado (CO) 80301, United States (USA)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3011326133079582679
KBI Biopharma, Inc.1101 Hamlin Rd., Durham, North Carolina (NC) 27704, United States (USA)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3004638264034248380
KBI Biopharma, Inc.47 National Dr, Durham, North Carolina (NC) 27703, United States (USA)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3017660941118524705
Neighbours

Registered in the same town

12
Compare

Comparable companies in United States

Enquiry

Common questions

Is KBI Biopharma, Inc. FDA approved?
KBI Biopharma, Inc. holds 4 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are KBI Biopharma, Inc.'s drugs manufactured?
At registered sites in Switzerland, the United States. The FDA register lists Plan-les-Ouates; Boulder, CO; Durham, NC. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.